© 1996 American Heart Association, Inc.
Articles |
High and Low Molecular Weight Fibroblast Growth Factor-2 Increase Proliferation of Neonatal Rat Cardiac Myocytes but Have Differential Effects on Binucleation and Nuclear Morphology
Evidence for Both Paracrine and Intracrine Actions of Fibroblast GrowthFactor-2
From the Department of Physiology (K.B.S.P., P.A.C.), University of Manitoba, Winnipeg, Canada, and the Departments of Anatomy and Physiology (E.K.), Division of Cardiovascular Sciences, St Boniface Hospital Research Centre, Winnipeg, Canada.
Abstract Basic fibroblast growth factor (FGF-2) plays a vital
role in the growth and differentiation of cardiac myocytes. It exists
in high and low molecular weight forms because of the use of
alternative initiation codons in the same mRNA. Higher levels of high
molecular weight forms (molecular mass of 22 and 21.5 kD) are
present in the rat heart during the neonatal stage, whereas the low
molecular weight form (molecular mass of 18 kD) is predominant in the
adult heart, suggesting different roles in development. Rat FGF-2 cDNAs
that can preferentially express high or low molecular weight forms were
introduced into neonatal rat ventricular myocyte cultures.
Significant and comparable increases in overall cardiac myocyte DNA
synthesis and proliferation were seen with 22/21.5- and 18-kD FGF-2
expression. A significantly higher mitotic index was seen in the
vicinity of cardiac myocytes overexpressing high or low molecular
weight forms of FGF-2 compared with nonoverexpressing cells. This
increase was inhibited in the presence of neutralizing antibodies to
FGF-2, pointing to a proximity-dependent paracrine effect of
22/21.5- and 18-kD FGF-2 on mitosis. By contrast, overexpression of
high but not low molecular weight FGF-2 was associated with a
significant increase in binucleation (
36% of cardiac myocytes
overexpressing 22/21.5-kD FGF-2 were binucleated compared with 9% of
cardiac myocytes overexpressing 18-kD FGF-2), which was not affected by
neutralizing antibodies to FGF-2. These results suggest that 22/21.5-kD
FGF-2 and 18-kD FGF-2 have similar paracrine effects on proliferation
but that 22-21.5-kD FGF-2 exerts a distinct intracrine effect on
binucleation.
Key Words: fibroblast growth factor • cardiac myocytes • binucleation • proliferation
This article has been cited by other articles:
 |
|
 |
|
  S. Y. Lu, D. P. Sontag, K. A. Detillieux, and P. A. Cattini FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1242 - C1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ahuja, P. Sdek, and W. R. MacLellan Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration Physiol Rev, April 1, 2007; 87(2): 521 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Sen, S. Khanna, and S. Roy Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart Cardiovasc Res, July 15, 2006; 71(2): 280 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhang, T. Anger, J. Su, J. Hao, X. Xu, M. Zhu, A. Gach, L. Cui, R. Liao, and U. Mende Selective Loss of Fine Tuning of Gq/11 Signaling by RGS2 Protein Exacerbates Cardiomyocyte Hypertrophy J. Biol. Chem., March 3, 2006; 281(9): 5811 - 5820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Vatner FGF Induces Hypertrophy and Angiogenesis in Hibernating Myocardium Circ. Res., April 15, 2005; 96(7): 705 - 707. [Full Text] [PDF]
|
|
|
|
|
|
F. Sheikh, C. J.A. Hirst, Y. Jin, M. E. Bock, R. R. Fandrich, B. E. Nickel, B. W. Doble, E. Kardami, and P. A. Cattini Inhibition of TGF{beta} signaling potentiates the FGF-2-induced stimulation of cardiomyocyte DNA synthesis Cardiovasc Res, December 1, 2004; 64(3): 516 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kardami, Z.-S. Jiang, S. K Jimenez, C. J Hirst, F. Sheikh, P. Zahradka, and P. A Cattini Fibroblast growth factor 2 isoforms and cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 458 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K Jimenez, F. Sheikh, Y. Jin, K. A Detillieux, J. Dhaliwal, E. Kardami, and P. A Cattini Transcriptional regulation of FGF-2 gene expression in cardiac myocytes Cardiovasc Res, June 1, 2004; 62(3): 548 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-S. Jiang, W. Srisakuldee, F. Soulet, G. Bouche, and E. Kardami Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion Cardiovasc Res, April 1, 2004; 62(1): 154 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Doble, X. Dang, P. Ping, R. R. Fandrich, B. E. Nickel, Y. Jin, P. A. Cattini, and E. Kardami Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes J. Cell Sci., January 22, 2004; 117(3): 507 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Claus, F. Doring, S. Gringel, F. Muller-Ostermeyer, J. Fuhlrott, T. Kraft, and C. Grothe Differential Intranuclear Localization of Fibroblast Growth Factor-2 Isoforms and Specific Interaction with the Survival of Motoneuron Protein J. Biol. Chem., January 3, 2003; 278(1): 479 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Detillieux, F. Sheikh, E. Kardami, and P. A. Cattini Biological activities of fibroblast growth factor-2 in the adult myocardium Cardiovasc Res, January 1, 2003; 57(1): 8 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B.S. Pasumarthi and L. J. Field Cardiomyocyte Cell Cycle Regulation Circ. Res., May 31, 2002; 90(10): 1044 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. A. Meij, F. Sheikh, S. K. Jimenez, P. W. Nickerson, E. Kardami, and P. A. Cattini Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H547 - H555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Naora, Y. Yang, F. J. Montz, J. D. Seidman, R. J. Kurman, and R. B. S. Roden A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells PNAS, March 27, 2001; 98(7): 4060 - 4065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sheikh, D. P. Sontag, R. R. Fandrich, E. Kardami, and P. A. Cattini Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1039 - H1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sheikh, R. R. Fandrich, E. Kardami, and P. A. Cattini Overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures Cardiovasc Res, June 1, 1999; 42(3): 696 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Arese, Y. Chen, R. Z. Florkiewicz, A. Gualandris, B. Shen, and D. B. Rifkin Nuclear Activities of Basic Fibroblast Growth Factor: Potentiation of Low-Serum Growth Mediated by Natural or Chimeric Nuclear Localization Signals Mol. Biol. Cell, May 1, 1999; 10(5): 1429 - 1444. [Abstract] [Full Text]
|
|
|
|
|
|
K. A. Detillieux, J. T. A. Meij, E. Kardami, and P. A. Cattini alpha 1-Adrenergic stimulation of FGF-2 promoter in cardiac myocytes and in adult transgenic mouse hearts Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H826 - H833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Corda, A. Mebazaa, M.-P. Gandolfini, C. Fitting, F. Marotte, J. Peynet, D. Charlemagne, J.-M. Cavaillon, D. Payen, L. Rappaport, et al. Trophic Effect of Human Pericardial Fluid on Adult Cardiac Myocytes : Differential Role of Fibroblast Growth Factor-2 and Factors Related to Ventricular Hypertrophy Circ. Res., November 19, 1997; 81(5): 679 - 687. [Abstract] [Full Text]
|
|
|
|
|
|
B. W. Doble, Y. Chen, D. G. Bosc, D. W. Litchfield, and E. Kardami Fibroblast Growth Factor-2 Decreases Metabolic Coupling and Stimulates Phosphorylation as Well as Masking of Connexin43 Epitopes in Cardiac Myocytes Circ. Res., October 1, 1996; 79(4): 647 - 658. [Abstract] [Full Text]
|
|
|
|
|
|
Q. Liu, H. Yan, N. J. Dawes, G. A. Mottino, J. S. Frank, and H. Zhu Insulin-like Growth Factor II Induces DNA Synthesis in Fetal Ventricular Myocytes In Vitro Circ. Res., October 1, 1996; 79(4): 716 - 726. [Abstract] [Full Text]
|
|